AFAlfred Ferrer Florensa

Alfred Ferrer Florensa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alfred Ferrer Florensa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Whole-genome prediction of bacterial pathogenic capacity on novel bacteria using protein language models with PathogenFinder2

    by Alfred Ferrer Florensa, Jose Juan Almagro Armenteros, Rolf Sommer Kaas, Philip Thomas Lanken Conradsen Clausen, Henrik Nielsen, Burkhard Rost, Frank Møller Aarestrup

    Infectious diseases continue to be a leading cause of mortality and pose a significant global health threat. Thus, the development of tools for surveillance and early detection of emerging pathogens is needed. We introduce PathogenFinder2, a novel, alignment-free, taxonomy-agnostic model for predicting bacterial pathogenic capacity in humans using protein language models. It outperforms previous methods, particularly for novel taxa, and provides interpretable outputs by highlighting proteins most relevant to pathogenic potential. These insights aid the identification of virulence factors, vaccine targets, and infection-related metabolic pathways. Furthermore, we introduce the Bacterial Pathogenic Capacity Landscape, which reveals patterns linked to host condition, infection site, microbial antagonism, and environmental origin. The model is freely available online at https://genepi.dk/pathogenfinder2, or as a standalone program (https://github.com/genomicepidemiology/PathogenFinder2). Supplementary data are available at Bioinformatics online.


  • Top Cited Papers
    Open Access

    Whole-genome prediction of bacterial pathogenic capacity on novel bacteria using protein language models, with PathogenFinder2

    by Alfred Ferrer Florensa, Jose Juan Almagro Armenteros, Rolf Sommer Kaas, Philip Thomas Lanken Conradsen Clausen, Henrik Nielsen, Burkhard Rost, Frank Møller Aarestrup

    Infectious diseases continue to be a leading cause of mortality and pose a significant global health threat. Thus the development of tools for surveillance and early detection of emerging pathogens is needed. In this study, we introduce PathogenFinder2, a novel predictor of bacterial pathogenic capacity in humans, available through an online server ( http://genepi.food.dtu.dk/pathogenfinder2 ), or as a standalone program ( https://github.com/genomicepidemiology/PathogenFinder2 ). The model, using protein language models for whole-genome phenotype prediction, surpasses the performance of previous methods, especially for novel bacterial taxa, while being taxonomy-agnostic and alignment-free. At the same time, it predicts the importance of each protein for the pathogenic capacity. This output might aid in characterizing potential pathogens, it readily identifies new candidates for virulence factors and vaccine targets, and offers insights into infection metabolic pathways. Furthermore, we introduce the Bacterial Pathogenic Landscape, revealing distributions related to the host conditions, antagonist bacteria, infection site, or habitat.


  • Open Access

    SpanSeq: similarity-based sequence data splitting method for improved development and assessment of deep learning projects

    by Alfred Ferrer Florensa, Jose Juan Almagro Armenteros, Henrik Nielsen, Frank Møller Aarestrup, Philip Thomas Lanken Conradsen Clausen

    The use of deep learning models in computational biology has increased massively in recent years, and it is expected to continue with the current advances in the fields such as Natural Language Processing. These models, although able to draw complex relations between input and target, are also inclined to learn noisy deviations from the pool of data used during their development. In order to assess their performance on unseen data (their capacity to generalize), it is common to split the available data randomly into development (train/validation) and test sets. This procedure, although standard, has been shown to produce dubious assessments of generalization due to the existing similarity between samples in the databases used. In this work, we present SpanSeq, a database partition method for machine learning that can scale to most biological sequences (genes, proteins and genomes) in order to avoid data leakage between sets. We also explore the effect of not restraining similarity between sets by reproducing the development of two state-of-the-art models on bioinformatics, not only confirming the consequences of randomly splitting databases on the model assessment, but expanding those repercussions to the model development. SpanSeq is available at https://github.com/genomicepidemiology/SpanSeq.


  • Top Cited Papers
    Open Access

    ResFinder – an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes

    by Alfred Ferrer Florensa, Rolf Sommer Kaas, Philip Thomas Lanken Conradsen Clausen, Derya Aytan-Aktug, Frank M. Aarestrup

    Antimicrobial resistance (AMR) is one of the most important health threats globally. The ability to accurately identify resistant bacterial isolates and the individual antimicrobial resistance genes (ARGs) is essential for understanding the evolution and emergence of AMR and to provide appropriate treatment. The rapid developments in next-generation sequencing technologies have made this technology available to researchers and microbiologists at routine laboratories around the world. However, tools available for those with limited experience with bioinformatics are lacking, especially to enable researchers and microbiologists in low- and middle-income countries (LMICs) to perform their own studies. The CGE-tools (Center for Genomic Epidemiology) including ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/) was developed to provide freely available easy to use online bioinformatic tools allowing inexperienced researchers and microbiologists to perform simple bioinformatic analyses. The main purpose was and is to provide these solutions for people involved in frontline diagnosis especially in LMICs. Since its original publication in 2012, ResFinder has undergone a number of improvements including improvement of the code and databases, inclusion of point mutations for selected bacterial species and predictions of phenotypes also for selected species. As of 28 September 2021, 820 803 analyses have been performed using ResFinder from 61 776 IP-addresses in 171 countries. ResFinder clearly fulfills a need for several people around the globe and we hope to be able to continue to provide this service free of charge in the future. We also hope and expect to provide further improvements including phenotypic predictions for additional bacterial species.